88 related articles for article (PubMed ID: 9486814)
1. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas.
Tartour E; Gey A; Sastre-Garau X; Lombard Surin I; Mosseri V; Fridman WH
J Natl Cancer Inst; 1998 Feb; 90(4):287-94. PubMed ID: 9486814
[TBL] [Abstract][Full Text] [Related]
2. Expression and polimorphism of IFN-gamma gene in patients with cervical cancer.
Kordi Tamandani MK; Sobti RC; Shekari M; Mukesh M; Suri V
Exp Oncol; 2008 Sep; 30(3):224-9. PubMed ID: 18806746
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of thymidine kinase in patients with cervical carcinoma.
Fujiwaki R; Hata K; Moriyama M; Iwanari O; Katabuchi H; Okamura H; Miyazaki K
Oncology; 2001; 61(1):47-54. PubMed ID: 11474248
[TBL] [Abstract][Full Text] [Related]
5. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications.
Wang S; Sun M; Gu C; Wang X; Chen D; Zhao E; Jiao X; Zheng J
Eur J Oral Sci; 2014 Jun; 122(3):202-9. PubMed ID: 24796206
[TBL] [Abstract][Full Text] [Related]
7. The antagonistic effect of interferon-beta on the interferon-gamma-induced expression of HLA-DR antigen in a squamous cell carcinoma line.
Naito Y; Baba T; Suzuki H; Uyeno K
J Exp Pathol; 1992; 6(1-2):75-87. PubMed ID: 1625040
[TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin (IL)-12 mRNA in gastric carcinoma specimens: cellular antitumor immune responses.
Katano M; Nakamura M; Kuwahara A; Fujimoto K; Matsunaga H; Miyazaki K; Morisaki T
J Surg Oncol; 1998 Jan; 67(1):11-7. PubMed ID: 9457250
[TBL] [Abstract][Full Text] [Related]
9. In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells.
Alcocer-González JM; Berumen J; Taméz-Guerra R; Bermúdez-Morales V; Peralta-Zaragoza O; Hernández-Pando R; Moreno J; Gariglio P; Madrid-Marina V
Viral Immunol; 2006; 19(3):481-91. PubMed ID: 16987066
[TBL] [Abstract][Full Text] [Related]
10. Modulation of human papillomavirus type 16 mRNA in cervical invasive carcinoma patients by interferon-alpha therapy.
García-Milián R; Rios MA; Amigó M; Díaz D; Guilar O; Silveira M; Araña MJ; Perea SE
J Interferon Cytokine Res; 1996 Sep; 16(9):739-43. PubMed ID: 8887059
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
Viladiu P; Bosch FX; Castellsagué X; Muñoz N; Escribà JM; Hamsíkova E; Hofmannova V; Guerrero E; Izquierdo A; Navarro C; Moreo P; Izarzugaza I; Ascunce N; Gili M; Muñoz MT; Tafur L; Shah KV; Vonka V
J Clin Oncol; 1997 Feb; 15(2):610-9. PubMed ID: 9053484
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
[TBL] [Abstract][Full Text] [Related]
15. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
[TBL] [Abstract][Full Text] [Related]
16. Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response.
van Driel WJ; Kievit-Tyson P; van den Broek LC; Zwinderman AH; Trimbos BJ; Fleuren GJ
Gynecol Oncol; 1999 Aug; 74(2):188-95. PubMed ID: 10419730
[TBL] [Abstract][Full Text] [Related]
17. Relative quantitative kinetics of interferon-gamma and interleukin-10 mRNA and protein production by activated ovine peripheral blood mononuclear cells.
Wattegedera SR; Watson DM; Hope JC; Kaiser P; Sales J; McInnes CJ; Entrican G
Vet Immunol Immunopathol; 2010 Jul; 136(1-2):34-42. PubMed ID: 20197203
[TBL] [Abstract][Full Text] [Related]
18. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
[TBL] [Abstract][Full Text] [Related]
19. Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA).
Bucht A; Larsson P; Weisbrot L; Thorne C; Pisa P; Smedegård G; Keystone EC; Grönberg A
Clin Exp Immunol; 1996 Mar; 103(3):357-67. PubMed ID: 8608632
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterisation of a group of cervical carcinoma patients with profound downregulation of intratumoral Type 1 (IFNgamma) and Type 2 (IL-4) cytokine mRNA expression.
Gey A; Kumari P; Sambandam A; Lecuru F; Cassard L; Badoual C; Fridman C; Nagarajan B; Fridman WH; Tartour E
Eur J Cancer; 2003 Mar; 39(5):595-603. PubMed ID: 12628838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
